3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Interventions
cabozantinib
2
Surveys and Questionnaires
2
Ipilimumab
2
Axitinib
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
brodalumab
1
belzutifan
1
atezolizumab
1
Selenomethionine
1
Ropivacaine
1
Radionuclide Imaging
1
Pluvicto
1
Patient Reported Outcome Measures
1
Methods
1
Magnetic Resonance Imaging
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Everolimus
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Sirolimus
×
30 days
×
Clear all
No trials found.